Anti-Cancer Drug Design
Bibliographic Information
International Title: |
Anti-Cancer Drug Design |
p-ISSN: |
0266-9536 Period: [1985 .. ] |
e-ISSN: |
1460-2148 Period: [ .. ] |
Country of publication: |
United States |
URL: |
http://www.cognizantcommunication.com/filecabi[..] |
Publishing House: |
Cognizant Communication Corporation |
ITAR Code: |
6730 |
NPI Scientific Field: |
Oncology |
Minimum Criteria
❌ Unregistered editorial board |
✅ Peer reviewed |
✅ Min. national authorship |
❌ Unregistered confirmed ISSN |
Open Access
Scientific level placements and Norwegian HEIs publication points
Year | Scientific Level | Author Shares | Publication Points |
---|---|---|---|
2024 | 0 | ||
2023 | 1 | 0.0 | 0.0 |
2022 | 1 | 0.0 | 0.0 |
2021 | 1 | 0.0 | 0.0 |
2020 | 1 | 0.0 | 0.0 |
2019 | 1 | 0.0 | 0.0 |
2018 | 1 | 0.0 | 0.0 |
2017 | 1 | 0.0 | 0.0 |
2016 | 1 | 0.0 | 0.0 |
2015 | 1 | 0.0 | 0.0 |
2014 | 1 | 0.0 | 0.0 |
2013 | 1 | 0.0 | 0.0 |
2012 | 1 | 0.0 | 0.0 |
2011 | 1 | 0.0 | 0.0 |
2010 | 1 | 0.0 | 0.0 |
2009 | 1 | 0.0 | 0.0 |
2008 | 1 | 0.0 | 0.0 |
2007 | 1 | 0.0 | 0.0 |
2006 | 1 | 0.0 | 0.0 |
2005 | 1 | 0.0 | 0.0 |
2004 | 1 | 0.0 | 0.0 |
Published in May the following year |
Comments
Comments regarding updates on the publication channel are only visible for you and the advisors. Comments regarding the scientific quality and levels will be public.
Login to comment